Clinical Trial

Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizophrenia

Completed
View on ClinicalTrials.gov →
Summary
The study aimed to test whether group reminiscence intervention for inpatients with schizophrenia is feasible, acceptable and preliminary effective. The effect of the intervention was evaluated on cognition, communication, and social function. Phase I was a multi-phase parallel study (n=38). The purpose of the study was to assess feasibility and preliminary efficacy by conducting an 8-week intervention with the participants. The study employed a single-group pretest-posttest evaluation. Phase II evaluated acceptability and performed a thematic analysis of semi-structured interviews conducted by a purposively selected subsample (N=8).
Trial Details
NCT Number NCT07512843
Lead Sponsor The Hashemite University
Conditions Schizophrenia Cognition Autobiographical Memory Cognitive Remediation, SCHIZOPHRENIA 1 (Disorder), Hospitalized Adult Patients
Enrollment 38 participants
Start Date 2025-02-01
Primary Completion 2025-08-29 (estimated)
Study Completion 2025-12-28 (estimated)
Updated on ClinicalTrials.gov 2026-04-06